Though she had subsequent eye pain and swelling necessitating repeated irrigation, the patient was able to undergo treatment for her papillary thyroid cancer and retained full function of her eye. This case highlights an approach that could be used for patients with nasolacrimal duct stenosis in ...
Simulations were performed for AuNP radii ranging from 2.5 nm to 20 nm radius, different cluster sizes and densities. The results show an increase of the energy deposit in the vicinity of the AuNP up to 150 nm. This effect nearly vanishes for distances up to one micron. For the case of...
While many studies have reported the occurrence of acute myeloid leukemia after high-dose RAI, there are few reports on chronic myeloid leukemia (CML) after low-dose RAI treatment. Moreover, previous cases of CML following thyroid cancer were reported before the tyrosine kinase inhibitor (TKI) ...
Second Primary Malignancy Risk in Thyroid Cancer Survivors Treated with Radioactive Iodine: An Updated Systematic Review and Meta-analysis Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid. 2009; 19(5): 451–457. Googl...
This cohort study evaluates the level of ionizing radiation exposure and risk of cancer death from a common treatment for hyperthyroidism in a large and
If the primary thyroid cancer treated with any type of radiation was the papillary subtype, the SIR was statistically significant (SIR, 1.69), but this finding was not seen for other thyroid cancer subtypes. "Although the risks of subsequent cancer do not outweigh the benefits of treatment, our...
Subbiah V, Kreitman RJ, Wainberg ZA, et al. Dabrafenib and trametinib treatment in patients with locally advanced or metastaticBRAFV600-mutant anaplastic thyroid cancer[J]. J Clin Oncol, 2018, 36(1): 7−13. DOI:10.1200/JCO.2017.73.6785. ...
Treatment plan system was used to design the distribution of the seed (125)I needed. Under CT guidance, the (125)I seeds of (2.2 - 3.3) Mq were implanted into the pancreatic cancer at a distance of 1.0 - 1.5 cm. A follow-up for 3 - 12 months was conducted. RESULTS: Complete ...
In the regime currently under in preliminary trials, each patient needs just four nanograms of Pb 212 in a single day of treatment, explained Bourdet. Theradioactive isotopeis aimed at thecancer cellsby chemically attaching it to an antibody crafted to recognize the tumor by it's specific anti...
The present invention relates to radioactive magnetic fluids, process for preparing them and use thereof. Particularly, the present invention relates to the radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof....